Sino Biopharmaceutical
1177.HK
#2120
Rank
HK$58.07 B
Marketcap
HK$3.19
Share price
0.63%
Change (1 day)
-2.65%
Change (1 year)
Sino Biopharmaceutical is a company based on Hong Kong that does R&D, production and sales of pharmaceuticals.

Revenue for Sino Biopharmaceutical (1177.HK)

Revenue in 2021 (TTM): HK$29.90 Billion

According to Sino Biopharmaceutical's latest financial reports the company's current revenue (TTM ) is HK$29.93 Billion. In 2020 the company made a revenue of HK$26.62 Billion a decrease over the revenue in the year 2019 that were of HK$27.27 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sino Biopharmaceutical from 2011 to 2021

Annual revenue

Year Revenue Change
2021 (TTM) HK$29.90 B12.32%
2020 HK$26.62 B-2.4%
2019 HK$27.27 B11.27%
2018 HK$24.51 B42.12%
2017 HK$17.25 B4.49%
2016 HK$16.51 B10.22%
2015 HK$14.97 B20.68%
2014 HK$12.41 B26.72%
2013 HK$9.79 B18.59%
2012 HK$8.25 B45.82%
2011 HK$5.66 B